ReNerve and RMIT awarded $499k grant
Filed with ASX · · 3 pages · English
Summary by 6ix AI
ReNerve Limited has announced that it, in collaboration with RMIT, has been awarded a grant for a nerve regeneration project. The funding will support research using patients' blood to enhance nerve regeneration after prostate surgery. This project aims to develop a gel that could be integrated into nerve repair products to improve surgical outcomes. ReNerve plans to keep shareholders updated on the project's progress as it develops.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Renerve
- ReNerve Secures Marketing Approval in India
- ReNerve Secures Marketing Approval in the Philippines
- Q4 FY26 Activities Report and Appendix 4C
- ReNerve Secures up to A$5 Million Funding Facility
- ReNerve Secures Marketing Approval in Indonesia
Later from Renerve
- ReNerve completes first cases in Hong Kong and Malaysia
- ReNerve AGM Presentation
- Positive FDA Feedback on NervAlign Nerve Guide Matrix
- Positive 12-Month Data for NervAlign Nerve Guide Matrix
- Q1 FY27 Activities Report and Appendix 4C
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve